FASTinov超快速流式细胞术直接用于阳性血培养药敏试验的评估
该研究在两个中心直接评估FASTinov流式细胞术药敏试剂盒(FASTgramneg和FASTgrampos)用于阳性血培养的性能,以纸片扩散法为参考。共纳入447份阳性血培养,FASTgramneg分类一致率基于EUCAST为96.8%、基于CLSI为96.4%;FASTgrampos两种标准下均为98.6%。试剂盒可在2小时内出结果,为快速药敏替代方案。
要点
- FASTgramneg和FASTgrampos试剂盒直接用于阳性血培养,分类一致率高。
- 基于EUCAST和CLSI标准,FASTgramneg一致率分别为96.8%和96.4%。
- FASTgrampos在两种标准下一致率均为98.6%,错误率低。
核心结论
- FASTinov流式细胞术试剂盒是阳性血培养直接药敏试验的快速替代方案,结果报告时间小于2小时。
研究设计与样本
- 在两个中心评估:葡萄牙FASTinov公司使用已知特征细菌加标的血培养,西班牙Ramón y Cajal大学医院使用患者阳性血培养。
- 共纳入447份阳性血培养,其中100份来自住院患者;以纸片扩散法为参考药敏方法。
主要发现
- FASTgramneg面板分类一致率基于EUCAST标准为96.8%,基于CLSI标准为96.4%。
- FASTgramneg面板基于EUCAST标准的错误率:2.1%微小错误、1.3%重大错误、0.6%极重大错误;基于CLSI标准:2.9%微小错误、0.9%重大错误、0.4%极重大错误。
- FASTgramneg面板的极重大错误主要见于阿莫西林-克拉维酸、头孢噻肟、头孢他啶和庆大霉素。
- FASTgrampos面板基于EUCAST标准的错误率:0.3%微小错误、1.4%重大错误、0.4%极重大错误(极重大错误涉及庆大霉素和葡萄球菌);基于CLSI标准:0.4%微小错误、1.4%重大错误、无极重大错误。
- FASTgrampos面板两种标准下分类一致率均为98.6%。
关键数值与推荐
- FASTgramneg面板分类一致率:EUCAST 96.8%,CLSI 96.4%。
- FASTgrampos面板分类一致率:EUCAST和CLSI均为98.6%。
- FASTgramneg面板错误率(EUCAST):2.1% mE、1.3% ME、0.6% VME;(CLSI):2.9% mE、0.9% ME、0.4% VME。
- FASTgrampos面板错误率(EUCAST):0.3% mE、1.4% ME、0.4% VME;(CLSI):0.4% mE、1.4% ME、无VME。
临床怎么用
- FASTinov流式细胞术试剂盒可直接从阳性血培养进行快速药敏试验,2小时内出结果,有助于个性化抗生素使用和抗菌药物管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The FASTinov flow cytometry kit, an ultrarapid antimicrobial susceptibility test, was directly evaluated on positive blood cultures (BC) at two sites: (i) FASTinov, S.A., in Porto, Portugal, using BC spiked with well-characterized bacteria, and (ii) Ramón y Cajal University Hospital in Madrid, Spain, using positive BC from patients. Two kits were evaluated, FASTgramneg (Enterobacterales, Pseudomonas, Acinetobacter) and FASTgrampos (Staphylococcus, Enterococcus). Dedicated software for cytometric data analysis and interpretative reporting, including both CLSI and EUCAST criteria, was used. The FASTgramneg kit also provides information about the presence of resistant mechanisms, including extended-spectrum beta-lactamases (ESBLs) and carbapenemases. After 1 h of incubation at 37°C, bacteria were analyzed using a CytoFLEX cytometer (Beckman, CA). Disk diffusion was performed as the reference susceptibility method. Overall, 447 positive BC were included, 100 from hospitalized patients. Categorical agreement values for the FASTgramneg panel were 96.8% based on EUCAST criteria and 96.4% based on CLSI criteria. For the FASTgrampos panel, categorical agreement was 98.6% when using both criteria. When EUCAST criteria were used, the percentages of errors for the FASTgramneg panel were 2.1% minor errors (mE), 1.3% major errors (ME), and 0.6% very major errors (VME). When CLSI criteria were used, 2.9% mE, 0.9% ME, and 0.4% VME were found. VME were mainly observed with amoxicillin-clavulanate, cefotaxime, ceftazidime, and gentamicin. The FASTgrampos panel showed 0.3% mE, 1.4% ME, and 0.4% VME when EUCAST criteria were used (VME with respect to gentamicin and Staphylococcus) and 0.4% mE, 1.4% ME, and no VME when CLSI criteria were used. The FASTinov flow cytometry kits represent a rapid alternative for direct antimicrobial susceptibility testing from positive BC, showing time to results of <2 h, and can be used to personalize antibiotic and stewardship practices.
引用
- Silva-Dias A, Pérez-Viso B, Martins-Oliveira I, et al. Evaluation of FASTinov Ultrarapid Flow Cytometry Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures. J Clin Microbiol. 2021. PMID: 34346718. doi:10.1128/JCM.00544-21
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。